While Ozempic received FDA approval for the management of type 2 diabetes, healthcare providers may prescribe it off-label for weight management in non-diabetic patients, especially if they have obesity-related health conditions
Weight Loss Potential Early Retatrutide clinical trials have shown noticeable weight reduction, with higher doses producing results that attracted attention in obesity research
Theyre working hard, but the biology of weight is complex
Their multiple mechanisms of action, which include significant weight loss, improved glycaemic control, blood pressure reduction, anti-inflammatory effects and potential direct cardioprotective and vascular effects, target multiple pathophysiological pathways implicated in HF progression
These arent the ones you want to wait out